BDMD
Baird Medical Investment Holdings LtdPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Aug 18 Baird Medical Investment Holdings Ltd (BDMD) received SEC effectiven…
- X Aug 31 Short interest jumps 42.3% to 34.6K
- R Sep 3 Baird Medical reported preliminary unaudited H1 2026 results with re…
- R Sep 3 Baird Medical reported preliminary H1 2026 revenue of $9.9M (+24.6%…
- X Sep 15 Short interest falls 26.4% to 25.5K
- R Sep 30 Baird Medical Investment Holdings Ltd entered into a securities purc…
- R Sep 30 Baird Medical reported H1 2026 unaudited results showing a dramatic…
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
69% below its 50-day average. New closing low $0.2705 on Oct 27.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | DOUBLED | $32.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Price is below the lowest target. Median implies +1379%.Targets as of Oct 27, 2026.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | $0.08 | $0.08–$0.08 | — | $27.5M |
| Next FY | $0.14 | $0.14–$0.14 | — | $32.5M |
Short side
FINRA· Oct 15, 2026SecBot reports
5 filings · 2 bullish · 2 bearish · 1 mixed- BEARISH 6-KSep 30, 2026
Baird Medical Investment Holdings Ltd entered into a securities purchase agreement to issue an 8%…
The heavily discounted convertible note with a low floor price and pre-delivery shares creates substantial potential dilution for existing shareholders. Monitor the stock price relative to the…
- MIXED 6-KSep 30, 2026
Baird Medical reported H1 2026 unaudited results showing a dramatic turnaround from a net loss of…
The H1 2026 results show a sharp but fragile turnaround, with the $4.8M licensing revenue masking a $3.0M decline in core device sales. The cash position ($289K) is critically low despite the ~$4M…
- BULLISH 6-KSep 3, 2026
Baird Medical reported preliminary unaudited H1 2026 results with revenue of $9.9M (+24.6% YoY)…
The operational turnaround is real but fragile — the company is burning cash and has thin liquidity ($289K cash vs. $10.8M short-term loans). Monitor the next 10-Q for cash flow trends and accounts…
- BULLISH PRESS-RELEASESep 3, 2026
Baird Medical reported preliminary H1 2026 revenue of $9.9M (+24.6% YoY) and swung to a net profit…
The strong operational turnaround and U.S. commercial momentum are positive signals, but results are preliminary and unaudited. Monitor upcoming full-year filings for confirmation and any regulatory…
All BDMD filing & press-release reports (5)
- 6-K reportSep 30, 2026
- 6-K reportSep 30, 2026
- 6-K reportSep 3, 2026
- PRESS-RELEASE reportSep 3, 2026
- EFFECT reportAug 18, 2026